Gossamer Historical Income Statement
| GOSS Stock | USD 1.28 0.11 7.91% |
Historical analysis of Gossamer Bio income statement accounts such as Selling General Administrative of 36.8 M or Total Revenue of 120.4 M can show how well Gossamer Bio performed in making a profits. Evaluating Gossamer Bio income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Gossamer Bio's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Gossamer Bio latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Gossamer Bio is a good buy for the upcoming year.
Gossamer |
About Gossamer Income Statement Analysis
Gossamer Bio Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Gossamer Bio shareholders. The income statement also shows Gossamer investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Gossamer Bio Income Statement Chart
Add Fundamental
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Gossamer Bio. It is also known as Gossamer Bio overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Most accounts from Gossamer Bio's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Gossamer Bio current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Gossamer Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. For more information on how to buy Gossamer Stock please use our How to Invest in Gossamer Bio guide.At this time, Gossamer Bio's Selling General Administrative is comparatively stable compared to the past year. Gross Profit is likely to gain to about 120.4 M in 2025, whereas Interest Income is likely to drop slightly above 1.6 M in 2025.
Gossamer Bio income statement Correlations
Click cells to compare fundamentals
Gossamer Bio Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Gossamer Bio income statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Interest Expense | 12.7M | 19.4M | 13.9M | 13.5M | 11.5M | 8.7M | |
| Selling General Administrative | 49.7M | 45.8M | 47.6M | 38.5M | 36.1M | 36.8M | |
| Gross Profit | (4.3M) | (5.2M) | (4.4M) | (4.4M) | 114.7M | 120.4M | |
| Other Operating Expenses | 210.6M | 216.0M | 218.5M | 183.8M | 174.6M | 157.3M | |
| Operating Income | (234.0M) | (216.1M) | (218.6M) | (183.8M) | (59.9M) | (62.9M) | |
| Net Income From Continuing Ops | (243.4M) | (234.0M) | (229.4M) | (187.4M) | (56.5M) | (59.4M) | |
| Ebit | (238.2M) | (214.5M) | (215.5M) | (173.8M) | (44.1M) | (46.3M) | |
| Research Development | 160.9M | 170.3M | 170.9M | 145.3M | 138.5M | 120.4M | |
| Ebitda | (234.0M) | (209.3M) | (211.1M) | (172.2M) | (40.0M) | (42.0M) | |
| Cost Of Revenue | 4.3M | 5.2M | 4.4M | 4.4M | 5.0M | 2.9M | |
| Total Operating Expenses | 210.6M | 216.0M | 218.5M | 183.8M | 174.6M | 157.3M | |
| Income Before Tax | (243.4M) | (234.0M) | (229.4M) | (179.8M) | (55.6M) | (58.4M) | |
| Total Other Income Expense Net | (9.4M) | (17.9M) | (10.8M) | 3.9M | 4.3M | 4.5M | |
| Net Income Applicable To Common Shares | (180.3M) | (243.4M) | (234.0M) | (229.4M) | (206.4M) | (216.8M) | |
| Net Income | (251.6M) | (249.1M) | (240.2M) | (179.8M) | (56.5M) | (59.4M) | |
| Income Tax Expense | 8.2M | 15.1M | 10.9M | 10M | 893K | 848.4K | |
| Depreciation And Amortization | 4.3M | 5.2M | 4.4M | 1.6M | 4.2M | 3.3M | |
| Reconciled Depreciation | 4.3M | 5.2M | 4.4M | 4.5M | 4.2M | 3.6M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Gossamer Stock Analysis
When running Gossamer Bio's price analysis, check to measure Gossamer Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gossamer Bio is operating at the current time. Most of Gossamer Bio's value examination focuses on studying past and present price action to predict the probability of Gossamer Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gossamer Bio's price. Additionally, you may evaluate how the addition of Gossamer Bio to your portfolios can decrease your overall portfolio volatility.